IFPMA’s Post

#AccessBiologicCoordinators recognize the significance of assisting patients in accessing specialty medications that provide innovative treatments for chronic conditions, ensuring cost does not impede access. Our team acknowledges the vital responsibility we have in fostering relationships with patients and guiding them through the complexities of pharmaceutical aid programs. We are dedicated to not just educating Biologic Coordinators but also helping them establish connections with patients, building trust, and assisting them in navigating the unfamiliar world of biologic medication. #PatientSupport #BiologicMedications #HealthcareAssistance #PharmaceuticalPrograms

#AccessBiologicCoordinators recognize the significance of assisting patients in accessing specialty medications that provide innovative treatments for chronic conditions, ensuring cost does not impede access. Our team acknowledges the vital responsibility we have in fostering relationships with patients and guiding them through the complexities of pharmaceutical aid programs. We are dedicated to not just educating Biologic Coordinators but also helping them establish connections with patients, building trust, and assisting them in navigating the unfamiliar world of biologic medication. #PatientSupport #BiologicMedications #HealthcareAssistance #PharmaceuticalPrograms

Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and Pharma: Pharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes. #finance #pharmacy #lifesciences

Is the Cure Worse Than the Disease? 💊📺 Explore the paradoxical world of pharmaceutical commercials - promising cures but revealing dangerous side effects. Dive into the impact of corporate medications on our health. #PharmaceuticalParadox #SideEffects #CorporateMedications #HealthRisks #CureOrCurse #MedicationDilemma #PharmaCommercials #HealthCareDeception #PatientSafety #MedicationAwareness

Electronic or paper based patient information leaflets? The debate for switching to electronic patient information leaflets is continuing both in EMEA and the US. The most important benefit from both pharmaceutical industry and healthcare professionals’ interest is that current and on-line updated product information is always electronically available, especially from drug safety perspective. However, elderly patients may not be able or do not feel comfortable to access online information. The challenge is how to manage the the medical information needs for all patients prescribed medicines. To find out what MILE - Medical Information Leaders in Europe is doing to improve patients access to medical information, contact info@mile-association.org https://lnkd.in/eZJEFwgP #medicalinformation #digitalhealth #misinformation #patients #medicines

Pharmacists and pharmacy practices shaping up… It’s been said a pharmacy first models is a huge undertaking. Yet, it’s a patient Centric approach to primary care: patients accessing certain medications including prescriptions without seeing a doctor first. What’s pharmacy only, prescription only and over the counter? What the deal? Why is important to get our regulatory authority to ML3 level? This conversation with Dr. Wairimu Mbogo was insightful on #onehealthlenspodcast. There’s much more to pharmaceutical industry especially when it comes to #uhc. Link in the comments.

Value-based healthcare is a game change for patient access. In our recent webinar, Experts Vesa Komssi and Mark Tolboom explore the importance of building partnership between the pharmaceutical industry and other health ecosystem stakeholders to enhance patient access: https://ow.ly/gI5u50SObXL

✨I'm thrilled to share that I've successfully completed the #VictorianOpioidpharmacotherapyProgram from Pharmaceutical Society of Australia 🎓 Let's dive into the key highlights: Purpose and Impact: The program aims to provide safe and effective treatment for individuals struggling with opioid dependence. Treatment Modalities: Methadone and buprenorphine are the cornerstones of this program. These medications act as replacement therapies, helping manage withdrawal symptoms and cravings. Policy and Guidelines: Staying informed about the **Policy for maintenance pharmacotherapy for opioid dependence** is essential. It outlines regulatory requirements and best practices. As practitioners, let's adhere to these guidelines to ensure optimal patient care. ✨Personally, completing this program has been enlightening. It reinforces my commitment to evidence-based practices and patient well-being.✨ #OpioidTreatment #HealthcareHeroes #LinkedInCommunity #opioids #APC #Pharmaceuticals #Australia

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, reaching a staggering 7.4 million patients in England alone! 😱 This surge has created significant challenges for pharmaceutical companies in ensuring patient access to medicines across the UK. 💊 At Apodi, we’ve delved into these issues and provided invaluable insights on how pharmaceutical companies can support the NHS in addressing these waiting lists, while improving access to essential medications. ⚕️ Curious about our findings and how we’re making a difference? Dive into our case study here 👉 https://lnkd.in/edpKraa9 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS

In the intricate landscape of pharmaceuticals, regulatory authorities play a crucial role in upholding safety and efficacy standards. The emphasis on compliance and quality assurance within compounding pharmacies is paramount for patient safety and therapeutic efficacy. Delve into our latest article for insights into how these standards uphold patient safety and medication consistency. Read more at https://ow.ly/7h7y50QyvVG and join the discussion on healthcare excellence! #RegulatoryCompliance #PatientSafety #HealthcareQuality #carieboydpharmaceuticals #compoundingpharmacist #compoundingpharmacy